Diabetes Care Market Research Reports & Industry Analysis

Diabetes stands for a kind of disease, especially diabetes mellitus, characterized by super high levels of glucose (sugar) in the blood. The product categories for this condition’s management fall within glucose monitoring devices (e.g. lancets, blood glucose meters) and insulin administration devices (e.g. insulin pumps, pens and syringes).

Globally, the Diabetes Care Market trends toward approaching far over EUR 19 billion by end-2018. The market will primarily be jet-propelled by the universal upsurge in the diabetes-stricken population, and the fast adoption tempos of less or non-invasive breakthroughs, including, among others, the EyeSense's blood glucose monitoring (BGM) devices, NBM-200G, 8 MediSensors' optical glucose monitoring technologies, Easy Check’s breath-based glucose testers. The dominating vendors in this marketplace include Roche, LifeScan, Sanofi, Novo Nordisk, Bayer Diabetes, and Lilly.

The research reports within the confines of this Catalogue analyze the Diabetes Care Market’s performance in a worldwide scenario, as well as across different geographies. The researches extensively review major market trends, driving forces and restraints for giving a clearer idea of the market structure. Additionally, the reports give unbiased insights into the competitive environment, major producers of anti-diabetic medications and diabetes devices, key products marketed and those currently in development. The global Diabetes Care Market forecasts are also available in the research reports.

Publications found: 409
Sort by:

Global Diabetes Disposable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

US$ 1,100.00

Diabetes Disposable Insulin Pen Market is likely to reach more than US$ 9 Billion across the ten ... followed by Spain by the end of 2022. The research report titled “Global Diabetes Disposable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast ...

July 2017 108 pages

Type 2 Diabetes Mellitus: KOL Insight 2016

US$ 7,900.00

... third-line setting? GLP1 agonists may be the top-ranked type 2 diabetes mellitus (T2DM) treatment according to the American Association of Clinical Endocrinologists ( ... ) Plus 18 more – download the full list now Sample of KOLS interviewed Dr. Silvio Inzucchi MD. Professor of Medicine, Yale University School of ...

September 2016 -

Diabetic Retinopathy Treatment - Global Market Outlook (2015-2022)

US$ 4,150.00

According to Stratistics MRC, the Global Diabetic Retinopathy Treatment market is expected to reach $10.24 billion by 2022. Rising prevalence of diabetics, increasing management financial support, change in lifestyle ... diabetic retinopathy market. Increase in awareness of diabetic retinopathy treatment and improvement of patient monitoring are some of the major trends in the market. The two main stages of diabetic retinopathy ...

March 2016 141 pages

Type 2 Diabetes Mellitus: Update Bulletin [Jan 2016]

US$ 995.00

Gain new KOL insights on the latest events happening in type 2 diabetes mellitus (T2DM): the future of inhaled insulin in the light of the licensing ... ’s biosimilar insulin glargine (Basaglar/Abasaglar). Key Questions Answered in this Update Bulletin: What do KOLs think about the future of inhaled insulin ...

January 2016 -

Global Diabetes Market Report: 2015 Edition

US$ 800.00

... -like-peptide-1 (GLP-1). The report “Global Diabetes Market” provides an in-depth analysis of the global diabetes market, along with an in-depth study of the regional markets. The major trends, growth ...

September 2015 66 pages

Type 2 Diabetes Mellitus: KOL Insight

US$ 7,495.00

... for new products? Type 2 Diabetes: KOL Insight is a comprehensive report that reveals the insights and opinions of 12 leading US and European KOLs. How they view ... KOL insights in Type 2 Diabetes: KOL Insight. Answers to Critical Questions SGLT-2 inhibitors look set to replace DPP-4 inhibitors in the second line add on setting: what do KOLs ...

July 2015 -

Global Diabetes Market Report: 2014 Edition

US$ 800.00

... include high diabetes cost which is a huge burden for families. This report offers a comprehensive analysis of the global diabetes market, along with ... an in-depth study of the regional market including the US, ...

October 2014 78 pages

Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC)

US$ 5,650.00

... the diabetes care devices market in Brazil, Russia, India, and China (BRIC) over the period 2009-2014. The report categorizes the overall market for diabetes care devices into the submarkets for insulin pumps, self-monitoring blood glucose systems, and continuous glucose monitoring systems. The diabetes care devices market ...

April 2011 151 pages

Insulin Delivery Devices Market Analysis and Future Forecast

US$ 850.00

Insulin Delivery Devices Market Analysis and Future Forecast published by Renub Research gives a detailed analysis on the global insulin market. The report analyses and forecast on market size of diff...

June 2009 54 pages

Filters

Search

Publishers

21
25
19
9
1
1
130
46
6
11
7
32
39
12
3
3
4
1
2
1
2
14
9
3
4
3
1

Regions

4
1
1
1
1
1
1
4
1
2
2
4
4
1
6
4
371

Price

Date

Pages

Offers